|

MS-553 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.1

Indications

  • Type 1 Diabetes With Diabetic Macular Edema1
  • Type 2 Diabetes With Diabetic Macular Edema1
  • Macular Edema1
  • Diabetic Macular Edema1
  • Diabetic Retinopathy1

Other1 trial

MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.